GlassScriptPhysician profile
Daniel Lee Richards
NPI 1538547740
$4,162.76
in general payments reported to CMS, 2019-2025
43 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $446 · 2021: $1,155 · 2022: $770 · 2023: $614 · 2024: $644 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,463 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,462.63 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $879.82 | 2019-2025 | |
| Daiichi Sankyo INC. | $534.80 | 2019-2025 | Injectafer |
| Mayne Pharma Commercial LLC | $447.10 | 2021-2025 | |
| Astellas Pharma US INC | $395.27 | 2023-2025 | Veozah |
| Pfizer INC. | $250.04 | 2020-2024 | |
| Hologic Sales and Service, LLC | $180.76 | 2019-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Gynesonics, INC. | $156.02 | 2021-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exeltis, USA INC. | $144.74 | 2020-2025 | Slynd |
| Evofem Biosciences, INC. | $122.77 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $98.87 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.02 | 2021-2025 | |
| Therapeuticsmd, INC. | $71.54 | 2020-2021 | |
| Sage Therapeutics, LLC | $62.10 | 2024-2025 | Zurzuvae |
| Optumhealth Care Solutions, LLC | $60.87 | 2023-2024 | Zyno Solutions, Vivify Health Care Team Portal, Vivify Health Care Team Portal 001 |
| Pacira Pharmaceuticals Incorporated | $50.53 | 2021-2023 | Exparel |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Momentis Surgical INC. | $49.00 | 2022 | |
| Novo Nordisk INC | $46.38 | 2022-2023 | |
| Avion Pharmaceuticals | $44.11 | 2021-2022 | |
| Cumberland Pharmaceuticals, INC. | $43.92 | 2019-2020 | |
| Becton, Dickinson and Company | $37.62 | 2022-2024 | Bd Onclarity |
| Endo Pharmaceuticals INC. | $33.74 | 2019-2020 | |
| Conmed Corporation | $26.79 | 2023 | Airseal, Conmed Specimen Retrieval |
| Organon LLC | $25.36 | 2021-2025 | Jada System |
| Ibsa Pharma INC. | $23.73 | 2019 | |
| Monaghan Medical Corporation | $22.17 | 2024 | Aerobika, Aeroeclipse |
| Corcept Therapeutics | $21.94 | 2022 | |
| Celgene Corporation | $17.83 | 2019 | |
| Solventum Corporation | $17.51 | 2025 | Prevena |
| Minerva Surgical, INC | $16.89 | 2025 | |
| Coloplast Corp | $16.18 | 2023 | |
| Intuitive Surgical, INC. | $16.09 | 2021 | |
| Olympus America INC. | $15.49 | 2022 | |
| Medicem INC. | $15.15 | 2023 | |
| Dysis Medical, INC. | $15.01 | 2021 | |
| Agile Therapeutics, INC. | $14.45 | 2021 | |
| Exact Sciences Corporation | $14.22 | 2023 | Cologuard Collection Kit |
| Microline Surgical INC | $13.92 | 2022 | |
| Biogen, INC. | $13.84 | 2024 | Zurzuvae |
| Amgen INC. | $12.62 | 2019 | |
| Lupin INC. | $12.55 | 2019 | |
| Scynexis, INC. | $12.00 | 2022 | |
| Roche Diagnostics Corporation | $11.72 | 2021 | |
| Merck Sharp & Dohme LLC | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.